| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2171025 | Cytotherapy | 2016 | 6 Pages |
Abstract
Despite considerable regulatory and clinical hurdles, the development and use of cell-based therapies are gaining momentum. As more of these therapies move toward commercial approval and larger-scale distribution, associated manufacturing and processing technologies are being advanced. Modern technologies directed at downstream processing seek to distribute such therapies from the manufacturing site to the patient more efficiently and reliably. Novel small-scale downstream solutions boost the transformation of cell therapies from abstraction to reality.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
R. Lee Buckler, Eric J. Kunkel, Maria L. Thompson, Rolf O. Ehrhardt,